Boston Scientific (BSX) CAPEX/Revenue US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
CAPEX/Revenue, % | 3.79% | 4.66% | 4.83% | 5.62% | 5.62% | 6.05% | |||
Changes by years, y/y, % | -1pp | +1pp | +0pp | +1pp | 0pp | +11.8% |
Boston Scientific. CAPEX/Revenue, %
Boston Scientific. CAPEX/Revenue, changes, pp
Boston Scientific (BSX) CAPEX/Revenue US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
CAPEX/Revenue, % | 5.84% | 7.17% | 7.17% | 6.35% | 3.76% | 6.05% | ||
Changes by years, y/y, % | +0pp | +1pp | +1pp | +3pp | -2pp | |||
Changes by quarters, q/q, % | +0pp | +1pp | 0pp | -1pp | -3pp |